• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于识别糖尿病性神经病变的即时检测腓肠神经传导装置的可靠性和有效性。

Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy.

作者信息

Lee Justin A, Halpern Elise M, Lovblom Leif E, Yeung Emily, Bril Vera, Perkins Bruce A

机构信息

Division of Endocrinology and Metabolism, Department of Medicine, University of Toronto, Ontario, Canada.

Division of Neurology, Department of Medicine, University of Toronto, Ontario, Canada.

出版信息

PLoS One. 2014 Jan 22;9(1):e86515. doi: 10.1371/journal.pone.0086515. eCollection 2014.

DOI:10.1371/journal.pone.0086515
PMID:24466129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3899274/
Abstract

BACKGROUND

Confirmation of diabetic sensorimotor polyneuropathy (DSP) relies on standard nerve conduction studies (NCS) performed in specialized clinics. We explored the utility of a point-of-care device (POCD) for DSP detection by nontechnical personnel and a validation of diagnostic thresholds with those observed in a normative database.

RESEARCH DESIGN AND METHODS

44 subjects with type 1 and type 2 diabetes underwent standard NCS (reference method). Two nontechnical examiners measured sural nerve amplitude potential (SNAP) and conduction velocity (SNCV) using the POCD. Reliability was determined by intraclass correlation coefficients (ICC [2], [1]). Validity was determined by Bland-Altman analysis and receiver operating characteristic curves.

RESULTS

The 44 subjects (50% female) with mean age 56 ± 18 years had mean SNAP and SNCV of 8.0 ± 8.6 µV and 41.5 ± 8.2 m/s using standard NCS and 8.0 ± 8.2 µV and 49.9 ± 11.1 m/s using the POCD. Intrarater reproducibility ICC values were 0.97 for SNAP and 0.94 for SNCV while interrater reproducibility values were 0.83 and 0.79, respectively. Mean bias of the POCD was -0.1 ± 3.6 µV for SNAP and +8.4 ± 6.4 m/s for SNCV. A SNAP of ≤6 µV had 88% sensitivity and 94% specificity for identifying age-and height-standardized reference NCS values, while a SNCV of ≤48 m/s had 94% sensitivity and 82% specificity [corrected].. Abnormality in one or more of these thresholds was associated with 95% sensitivity and 71% specificity for identification of DSP according to electrophysiological criteria.

CONCLUSIONS

The POCD demonstrated excellent reliability and acceptable accuracy. Threshold values for DSP identification validated those of published POCD normative values. We emphasize the presence of measurement bias--particularly for SNCV--that requires adjustment of threshold values to reflect those of standard NCS.

摘要

背景

糖尿病感觉运动性多发性神经病变(DSP)的确诊依赖于在专业诊所进行的标准神经传导研究(NCS)。我们探讨了一种即时检测设备(POCD)用于非专业人员检测DSP的效用,并对诊断阈值与在规范数据库中观察到的阈值进行了验证。

研究设计与方法

44名1型和2型糖尿病患者接受了标准NCS(参考方法)。两名非专业检查人员使用POCD测量腓肠神经动作电位(SNAP)和传导速度(SNCV)。可靠性通过组内相关系数(ICC[2,1])确定。有效性通过Bland-Altman分析和受试者工作特征曲线确定。

结果

44名受试者(50%为女性),平均年龄56±18岁,使用标准NCS时平均SNAP和SNCV分别为8.0±8.6µV和41.5±8.2m/s,使用POCD时分别为8.0±8.2µV和49.9±11.1m/s。检查者内部重复性ICC值SNAP为0.97,SNCV为0.94,而检查者间重复性值分别为0.83和0.79。POCD的平均偏差SNAP为-0.1±3.6µV,SNCV为+8.4±6.4m/s。SNAP≤6µV对识别年龄和身高标准化的参考NCS值具有88%的敏感性和94%的特异性,而SNCV≤48m/s具有94%的敏感性和82%的特异性[校正后]。根据电生理标准,这些阈值中一个或多个异常与识别DSP的95%敏感性和71%特异性相关。

结论

POCD显示出优异的可靠性和可接受的准确性。DSP识别的阈值验证了已发表的POCD规范值。我们强调存在测量偏差——尤其是对于SNCV——这需要调整阈值以反映标准NCS的阈值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/6494972f4022/pone.0086515.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/7d1335135c91/pone.0086515.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/a0a6367ed2f9/pone.0086515.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/6494972f4022/pone.0086515.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/7d1335135c91/pone.0086515.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/a0a6367ed2f9/pone.0086515.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5451/3899274/6494972f4022/pone.0086515.g003.jpg

相似文献

1
Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy.用于识别糖尿病性神经病变的即时检测腓肠神经传导装置的可靠性和有效性。
PLoS One. 2014 Jan 22;9(1):e86515. doi: 10.1371/journal.pone.0086515. eCollection 2014.
2
The utility of a point-of-care sural nerve conduction device for detection of diabetic polyneuropathy: A cross-sectional study.即时检测腓肠神经传导装置在诊断糖尿病周围神经病变中的效用:一项横断面研究。
Muscle Nerve. 2019 Feb;59(2):187-193. doi: 10.1002/mus.26361. Epub 2018 Dec 24.
3
Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy.一种用于检测糖尿病感觉运动性多发性神经病变的新型即时检测神经传导装置的验证
Diabetes Care. 2006 Sep;29(9):2023-7. doi: 10.2337/dc08-0500.
4
Validity of a point-of-care nerve conduction device for polyneuropathy identification in older adults with diabetes: Results from the Canadian Study of Longevity in Type 1 Diabetes.一种即时神经传导设备用于识别老年糖尿病多发性神经病的有效性:来自 1 型糖尿病加拿大长寿研究的结果。
PLoS One. 2018 Apr 30;13(4):e0196647. doi: 10.1371/journal.pone.0196647. eCollection 2018.
5
Validity and reliability of a point-of-care nerve conduction device in diabetes patients.在糖尿病患者中即时神经传导装置的有效性和可靠性。
J Diabetes Investig. 2019 Sep;10(5):1291-1298. doi: 10.1111/jdi.13007. Epub 2019 Feb 8.
6
Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring.使用即时护理神经传导设备评估糖尿病性神经病变显示,其与LDIFLARE方法及临床神经病变评分存在显著关联。
J Diabetes Sci Technol. 2015 Jan;9(1):123-31. doi: 10.1177/1932296814551044. Epub 2014 Sep 17.
7
Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck™).在使用即时周边神经传导装置(NC-stat®/DPNCheck™)诊断糖尿病多发性周围神经病时,可能需要考虑西方人和日本人之间神经传导参数正常限值的差异。
J Diabetes Investig. 2018 Sep;9(5):1173-1181. doi: 10.1111/jdi.12818. Epub 2018 Mar 6.
8
Clinical utility of dorsal sural nerve conduction studies in healthy and diabetic children.健康及糖尿病儿童腓肠背侧神经传导研究的临床应用
Clin Neurophysiol. 2004 Jun;115(6):1452-6. doi: 10.1016/j.clinph.2004.01.003.
9
Sural-to-radial amplitude ratio in the diagnosis of diabetic sensorimotor polyneuropathy.比目鱼肌-桡骨振幅比在诊断糖尿病感觉运动性多发性神经病中的作用。
Muscle Nerve. 2012 Jan;45(1):126-7. doi: 10.1002/mus.22166.
10
Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.使用神经传导研究参数的个体和简单组合来识别和预测糖尿病感觉运动多发性神经病。
PLoS One. 2013;8(3):e58783. doi: 10.1371/journal.pone.0058783. Epub 2013 Mar 22.

引用本文的文献

1
Diagnostic advancements in early detection of diabetic neuropathy: comparative analysis of medial and lateral plantar nerve degeneration.糖尿病性神经病变早期检测中的诊断进展:足底内侧和外侧神经变性的比较分析
Ann Med Surg (Lond). 2025 May 30;87(7):4325-4335. doi: 10.1097/MS9.0000000000003441. eCollection 2025 Jul.
2
Sheffield One-Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes.谢菲尔德一站式服务:提高糖尿病周围神经病变和其他糖尿病微血管并发症筛查率的潜在模式。
J Diabetes Investig. 2024 Oct;15(10):1355-1362. doi: 10.1111/jdi.14268. Epub 2024 Jul 22.
3

本文引用的文献

1
Neuropathy.神经病变
Can J Diabetes. 2013 Apr;37 Suppl 1:S142-4. doi: 10.1016/j.jcjd.2013.01.039. Epub 2013 Mar 26.
2
Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes.角膜神经与 1 型糖尿病常规小纤维检测的结构-功能关系。
Diabetes Care. 2013 Sep;36(9):2748-55. doi: 10.2337/dc12-2075. Epub 2013 Apr 11.
3
Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters.
Pathological evaluation of the pathogenesis of diabetes mellitus and diabetic peripheral neuropathy.
糖尿病发病机制及糖尿病周围神经病变的病理学评价。
Pathol Int. 2024 Aug;74(8):438-453. doi: 10.1111/pin.13458. Epub 2024 Jun 18.
4
Assessment of the severity of diabetic polyneuropathy aids in predicting the risk of developing diabetic complications in patients with untreated diabetes.评估糖尿病多发性神经病的严重程度有助于预测未治疗糖尿病患者发生糖尿病并发症的风险。
Front Endocrinol (Lausanne). 2024 Mar 15;15:1380970. doi: 10.3389/fendo.2024.1380970. eCollection 2024.
5
Reliability of a novel point of care device for monitoring diabetic peripheral neuropathy.一种新型即时检测设备监测糖尿病周围神经病变的可靠性。
Sci Rep. 2023 Nov 3;13(1):19043. doi: 10.1038/s41598-023-45841-6.
6
Risk factors for the development of tinea pedis and onychomycosis: Real-world evidence from a single-podiatry center, large-scale database in Japan.足癣和甲真菌病发展的危险因素:来自日本单一足病中心、大规模数据库的真实世界证据。
J Dermatol. 2024 Jan;51(1):30-39. doi: 10.1111/1346-8138.16991. Epub 2023 Oct 30.
7
The Composite Autonomic Symptom Score 31 Questionnaire: A Sensitive Test to Detect Risk for Autonomic Neuropathy.《综合自主症状评分 31 问卷》:一种用于检测自主神经病变风险的敏感测试。
J Diabetes Res. 2023 Aug 9;2023:4441115. doi: 10.1155/2023/4441115. eCollection 2023.
8
Association between Diabetic Peripheral Neuropathy as Measured Using a Point-of-Care Sural Nerve Conduction Device and Urinary Albumin Excretion in Patients with Type 2 Diabetes.使用即时检测腓肠神经传导装置测量的糖尿病周围神经病变与2型糖尿病患者尿白蛋白排泄之间的关联
J Clin Med. 2023 Jun 16;12(12):4089. doi: 10.3390/jcm12124089.
9
Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN).糖尿病感觉运动神经病(DSPN)的诊断和治疗方法研究进展。
Front Endocrinol (Lausanne). 2023 May 18;14:1165505. doi: 10.3389/fendo.2023.1165505. eCollection 2023.
10
Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy.2型糖尿病周围神经病变患者较低的内脏脂肪面积
Diabetes Metab Syndr Obes. 2022 Nov 21;15:3639-3654. doi: 10.2147/DMSO.S388330. eCollection 2022.
使用神经传导研究参数的个体和简单组合来识别和预测糖尿病感觉运动多发性神经病。
PLoS One. 2013;8(3):e58783. doi: 10.1371/journal.pone.0058783. Epub 2013 Mar 22.
4
Diabetic neuropathy.糖尿病性神经病变
Continuum (Minneap Minn). 2012 Feb;18(1):60-84. doi: 10.1212/01.CON.0000411568.34085.3e.
5
The rising tide of diabetes mellitus in a Chinese population: a population-based household survey on 121,895 persons.中国人群中糖尿病患病率的上升趋势:一项针对 121895 人的基于人群的家庭调查。
Int J Public Health. 2013 Apr;58(2):269-76. doi: 10.1007/s00038-012-0364-y. Epub 2012 May 3.
6
Nerve conduction studies.神经传导研究。
Aust Fam Physician. 2011 Sep;40(9):693-7.
7
Dorsal versus ventral monofilament testing of the great toe for the identification of diabetic sensorimotor polyneuropathy.大脚趾背侧和腹侧单丝检查用于诊断糖尿病感觉运动多发性神经病。
Diabetes Res Clin Pract. 2011 Aug;93(2):e71-e73. doi: 10.1016/j.diabres.2011.05.001. Epub 2011 May 31.
8
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy.体内角膜共焦显微镜作为一种新型的早期糖尿病感觉运动多发性神经病筛查试验的可重复性。
Diabet Med. 2011 Oct;28(10):1253-60. doi: 10.1111/j.1464-5491.2011.03299.x.
9
Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.糖尿病性神经病变:定义、诊断标准、严重程度评估和治疗的更新。
Diabetes Care. 2010 Oct;33(10):2285-93. doi: 10.2337/dc10-1303.
10
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial.症状与体征与神经传导研究诊断糖尿病感觉运动性多神经病:Cl 与 NPhys 试验。
Muscle Nerve. 2010 Aug;42(2):157-64. doi: 10.1002/mus.21661.